Rural communities are disproportionately impacted by the nation?s current opioid epidemic. While access to buprenorphine, the gold standard of pharmaceutical treatment for opioid use disorder (OUD), has increased in rural areas, these communities continue to experience a shortage of providers who are authorized to prescribe this medication (Andrilla & Patterson, 2021; Mattick et al., 2014; Thomas et al., 2014). This study sought to understand the experiences of APRNs treating patients with OUD in rural Oregon, the real and perceived barriers to buprenorphine prescribing, and the facilitation strategies that could motivate providers to add or maintain this service.